Caregiver Perspectives on MECP2 Duplication Syndrome: Experiences With Symptoms, Diagnosis, and Treatment

A 95-item survey was developed to capture perceptions of caregivers of people with MECP2 duplication syndrome (MDS) regarding caregiver-reported symptoms, the diagnostic pathway, impacts on quality of life (QoL), treatment, and therapy goals. Participants were self-reported adult caregivers of individuals with MDS identified through global MDS patient registries. Fifty-seven caregivers completed the survey from May 4 to 13, 2022. Among caregiver-reported symptoms, speech and motor delays were the most common, seizures the most concerning, and poor language skills the most detrimental to QoL. Caregivers reported challenges obtaining genetic testing or counseling (42%) and felt sadness, anxiety, and depression on receiving diagnoses. MDS symptoms were managed with multiple antiseizure medications (68%), antibiotics/antivirals for those with respiratory infections (69%), and over-the-counter supplements or stool softeners (57%). Caregivers were most interested in a new therapy to improve independent walking. Additional resources and disease-modifying treatments are needed to support individuals with MDS and their caregivers.

Authors

Institutions

Publication Details

Journal
Journal of Child Neurology
Published
2026-11-13
DOI
https://doi.org/10.1177/08830738261503422
Primary Topic
Genetics and Neurodevelopmental Disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Caregiver Perspectives on MECP2 Duplication Syndrome: Experiences With Symptoms, Diagnosis, and Treatment

Sarika U. Peters, Davut Pehli̇van, Christine M. Coquery, Paul R. V. Malik et al.
1 links
Journal of Child Neurology
Genetics and Neurodevelopmental Disorders
article

Caregiver Perspectives on MECP2 Duplication Syndrome: Experiences With Symptoms, Diagnosis, and Treatment

Sarika U. Peters, Davut Pehli̇van, Christine M. Coquery, Paul R. V. Malik, Aron Schmidt, Pete Anderson, Courtney Bisbee, Jason Frank
article en

Abstract

A 95-item survey was developed to capture perceptions of caregivers of people with MECP2 duplication syndrome (MDS) regarding caregiver-reported symptoms, the diagnostic pathway, impacts on quality of life (QoL), treatment, and therapy goals. Participants were self-reported adult caregivers of individuals with MDS identified through global MDS patient registries. Fifty-seven caregivers completed the survey from May 4 to 13, 2022. Among caregiver-reported symptoms, speech and motor delays were the most common, seizures the most concerning, and poor language skills the most detrimental to QoL. Caregivers reported challenges obtaining genetic testing or counseling (42%) and felt sadness, anxiety, and depression on receiving diagnoses. MDS symptoms were managed with multiple antiseizure medications (68%), antibiotics/antivirals for those with respiratory infections (69%), and over-the-counter supplements or stool softeners (57%). Caregivers were most interested in a new therapy to improve independent walking. Additional resources and disease-modifying treatments are needed to support individuals with MDS and their caregivers.

Journal of Child Neurology
Baylor College of Medicine (US), Texas Children's Hospital (US), Vanderbilt University Medical Center (US)
Ionis Pharmaceuticals
Good health and well-being
Genetics and Neurodevelopmental Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon